Sarcoma is a rare cancer with 100+ subtypes, making diagnosis and treatment challenging. There’s no cure, and current therapies have harsh side effects. Join us in raising awareness and supporting research for safer, more effective treatments—and a cure. #SarcomaAwareness

Great news! Discovery now offers 10x Genomics Xenium services for advanced in situ spatial transcriptomics, providing high-resolution spatial gene expression profiling. Learn more in this new video: . #SpatialBiology #Transcriptomics #10XGenomics #Xenium.

We celebrate #Juneteenth and reflect on the opportunities available to all of us to support racial justice and equality for all in our everyday lives. #honoringjuneteenthtogether

We’re proud to announce that our Newtown, PA facility has been awarded the Green Certification by the @My_Green_Lab. This is a distinction achieved by only a select group of labs worldwide, recognizing our commitment to sustainability, safety, and environmental stewardship!

The FDA has approved the first blood test for early detection of Alzheimer’s disease—a major milestone for patients and clinicians. The Lumipulse test measures pTau217 and ß-Amyloid 1-42 proteins to predict amyloid plaque presence. Read more here:

Discovery fosters a culture that values open conversations, mental wellness, and access to care. This Men’s Health Month and Men’s Mental Health Awareness Day (June 13), we’re encouraging the men in our lives to prioritize both their physical and mental well-being. #MensHealth

AbbVie’s c-Met–directed ADC, Emrelis, has received accelerated FDA approval to treat advanced or metastatic non-squamous non-small cell lung cancer (NSCLC), demonstrating a 35% overall response rate (ORR) during clinical testing: #ADC #Oncology.

Are you heading to #EACR2025 Congress in Lisbon, Portugal this summer? Connect with us and schedule a meeting to learn more about Discovery’s oncology solutions. We look forward to learning about the latest breakthroughs and meeting with cancer researchers from around the world!

Alzheimer’s disease and other brain conditions are on the rise. Read how research using RNA-seq shows white matter hyperintensities (WMHs) in Alzheimer’s involve distinct biological mechanisms vs. normal aging. #ENDALZ #alzheimersandbrainawarenessmonth

Now available: Primary Human Mast Cells! Fresh, functional & fully characterized, these cells are ideal for allergy & inflammation drug development. Learn more here: #AllergyResearch #Inflammation #DrugDevelopment #MastCells #Biospecimens

During #PrideMonth, we celebrate the contributions and resilience of the LGBTQ+ community, recognizing the courage that continue to inspire us all. Today, and every day, we stand with you and welcome all who choose their most authentic selves. #PrideMonth #LGBTQIA

Our proteomics scientist, Dr. Jessica Moore will be presenting at a breakfast workshop hosted by @thermofisher during the annual ASMS Conference on June 4, in Baltimore. Register today to save your spot in the workshop! . #ASMS #ASMS2025

Our leadership team visited our Newtown, PA facility to tour the lab where our high-quality IHC and Histopathology services are performed. It was a valuable opportunity to engage with the on-site team and review our key platforms and the critical work we do for our customers.

This AAPI Month, we celebrate Yuki Kato Maves, a business leader driving innovation and growth across our products and services. Yuki is proud of her Japanese Heritage and grateful to be part of a diverse scientific community dedicated to advancing science. #AAPI #WomeninSTEM

Meet with us at the 25th #ASCO Annual Meeting, May 30–June 3 at McCormick Place, Chicago. We look forward to engaging with oncology leaders within the clinical space and collaborating on advancing the future of cancer care. Schedule a meeting:

City of Hope’s experimental therapy AOH1996 reduced liver metastases by up to 49% in early clinical testing. The therapy targets transcription-replication conflicts, a genetic vulnerability in pancreatic cancer cells with KRAS mutations.

Why 80% of CDx Projects Stall - And How to Fix It . Struggling to streamline companion diagnostic development? . Join leading biopharma experts who've transformed their CDx pipeline. Download now to unlock precision medicine success!

Mental health is just as important as physical health, and it deserves the same care and attention. During this month, we recognize the importance of compassion, self-care, and supporting one another, because every conversation can make a difference. #MentalHealth

Lexeo Therapeutics' gene therapy candidate LX2006 demonstrates positive interim data to treat Friedreich ataxia (FA). Patients showed improvements in cardiac biomarkers and function, highlighting its potential as a first-in-class treatment. #GeneTherapy.

Representation matters. This month, we honor the trailblazing Asian American and Pacific Islander (AAPI) leaders whose resilience and hard work have driven progress in science, medicine, and beyond—paving the way for the next generation of AAPI scientists. #AAPIHeritageMonth